Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial
Tomasz J. Guzik, Chinthanie Ramasundarahettige, Nana Pogosova, Patricio López‐Jaramillo, Leanne Dyal, Scott D. Berkowitz, Eva Muehlhofer, Deepak L. Bhatt, Keith A.A. Fox, Salim Yusuf, John W. Eikelboom
Topics & Concepts
MedicineRivaroxabanAspirinOverweightCompassInternal medicineObesityPhysical therapyWarfarinAtrial fibrillationGeographyCartographyAtrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular DiseasesVenous Thromboembolism Diagnosis and Management